Chemical Structure (95ffd367 9b0c 4f75 8487 5d8f3c0a5ad0 01)
Wayrilz Tablet, Film Coated
Product Images NDC 58468-0251
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Wayrilz (NDC 58468-0251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (60 Tablet Carton)
This is information about tablets called Wayrilz (rilzabrutinib) containing 60 tablets manufactured for sanofi. The recommended dosage and storage instructions are provided, including details on room temperature storage and protecting from light and moisture. A warning to keep out of children's reach is emphasized. Additionally, a website is provided for more information.*
Principal Display Panel (28 Tablet Blister Pack)
This description is not available.*
Principal Display Panel (56 Tablet Blister Pack Carton)
WAYRILZ A (rilzabrutinib) tablets are available in a dosage of 400 mg per tablet. Each packaging contains a total of 56 tablets, divided into two blister packs of 28 tablets each. It is a product from Sanofi, a reputable pharmaceutical company. The NDC for this product is 58468-0251-5.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
